|
BRPI0721138A2
(pt)
|
2006-12-22 |
2014-04-01 |
Hoffmann La Roche |
Derivados de espiro-piperidina
|
|
AU2013201306B2
(en)
*
|
2007-03-12 |
2015-11-12 |
Glaxosmithkline Llc |
Phenyl Amino Pyrimidine Compounds and Uses Thereof
|
|
KR101566840B1
(ko)
|
2007-03-12 |
2015-11-06 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
페닐 아미노 피리미딘 화합물 및 이의 용도
|
|
AU2016200866B2
(en)
*
|
2007-03-12 |
2017-06-22 |
Glaxosmithkline Llc |
Phenyl amino pyrimidine compounds and uses thereof
|
|
US8507511B2
(en)
*
|
2007-04-24 |
2013-08-13 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
JP5611826B2
(ja)
|
2007-09-04 |
2014-10-22 |
ザ スクリプス リサーチ インスティテュート |
タンパク質キナーゼ阻害剤としての置換されたピリミジニル−アミン
|
|
WO2009087127A1
(en)
|
2008-01-11 |
2009-07-16 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
JP5328816B2
(ja)
|
2008-02-22 |
2013-10-30 |
エフ．ホフマン−ラ ロシュ アーゲー |
アミロイドβの調節薬
|
|
WO2010040661A1
(en)
|
2008-10-09 |
2010-04-15 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
AU2009312856A1
(en)
|
2008-11-10 |
2010-05-14 |
F. Hoffmann-La Roche Ag |
Heterocyclic gamma secretase modulators
|
|
EP2488503A1
(en)
*
|
2009-10-12 |
2012-08-22 |
Myrexis, Inc. |
Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
|
|
KR101445012B1
(ko)
|
2009-12-17 |
2014-09-26 |
머크 샤프 앤드 돔 코포레이션 |
Ｓｙｋ 억제제로서의 아미노피리미딘
|
|
EP2512246B1
(en)
|
2009-12-17 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
US8486967B2
(en)
|
2010-02-17 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Heteroaryl substituted piperidines
|
|
JP5996532B2
(ja)
|
2010-07-15 |
2016-09-21 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
有害生物防除剤としての新規複素環式化合物
|
|
GB201012105D0
(en)
*
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
EP2598660B1
(en)
|
2010-07-26 |
2017-03-15 |
Biomatrica, INC. |
Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
|
|
WO2012018639A2
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
|
|
BR112013009823A2
(pt)
|
2010-10-22 |
2016-07-05 |
Bayer Ip Gmbh |
novos compostos heterocíclicos como pesticidas
|
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
|
EP2681215B1
(en)
|
2011-02-28 |
2015-04-22 |
Array Biopharma, Inc. |
Serine/threonine kinase inhibitors
|
|
JP6147727B2
(ja)
|
2011-04-01 |
2017-06-14 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
チロシン受容体キナーゼｂｔｋ阻害剤としての置換ｎ−（３−（ピリミジン−４−イル）フェニル）アクリルアミド類似体
|
|
MX2013011908A
(es)
*
|
2011-04-12 |
2014-03-27 |
Alzheimer S Inst Of America Inc |
Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
|
|
EP2699554B1
(en)
|
2011-04-19 |
2016-11-02 |
Bayer Intellectual Property GmbH |
Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
|
|
EP2706853B1
(en)
|
2011-05-10 |
2017-06-14 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
CA2834062A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
AR087119A1
(es)
*
|
2011-07-12 |
2014-02-12 |
Dow Agrosciences Llc |
Composiciones plaguicidas y procesos relacionados
|
|
US9187462B2
(en)
|
2011-08-04 |
2015-11-17 |
Array Biopharma Inc. |
Substituted quinazolines as serine/threonine kinase inhibitors
|
|
DE102011112978A1
(de)
*
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
|
JP5976814B2
(ja)
|
2011-09-16 |
2016-08-24 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
スルホキシイミン基を含有する二置換５−フルオロピリミジン誘導体
|
|
EP2755956B1
(en)
|
2011-09-16 |
2016-05-18 |
Bayer Intellectual Property GmbH |
2,4-disubstituted 5-fluoro-pyrimidines as selective cdk9 inhibtors
|
|
DK2820009T3
(en)
|
2012-03-01 |
2018-04-16 |
Array Biopharma Inc |
Serine / threonine kinase inhibitors
|
|
RS58514B1
(sr)
|
2012-06-13 |
2019-04-30 |
Incyte Holdings Corp |
Supstituisana triciklična jedinjenja kao inhibitori fgfr
|
|
US8809359B2
(en)
|
2012-06-29 |
2014-08-19 |
Ym Biosciences Australia Pty Ltd |
Phenyl amino pyrimidine bicyclic compounds and uses thereof
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
TW201408658A
(zh)
|
2012-08-27 |
2014-03-01 |
Array Biopharma Inc |
絲胺酸／酥胺酸激酶抑制劑
|
|
CA2887465A1
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
WO2014055928A2
(en)
*
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
CN105102434A
(zh)
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
WO2014060375A2
(en)
|
2012-10-18 |
2014-04-24 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
US9725703B2
(en)
|
2012-12-20 |
2017-08-08 |
Biomatrica, Inc. |
Formulations and methods for stabilizing PCR reagents
|
|
GB201303109D0
(en)
|
2013-02-21 |
2013-04-10 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
PH12015502383B1
(en)
|
2013-04-19 |
2023-02-03 |
Incyte Holdings Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
WO2015002729A2
(en)
|
2013-06-13 |
2015-01-08 |
Biomatrica, Inc. |
Cell stabilization
|
|
ES2786373T3
(es)
|
2014-06-10 |
2020-10-09 |
Biomatrica Inc |
Estabilización de trombocitos a temperaturas ambiente
|
|
TWI729644B
(zh)
|
2014-06-12 |
2021-06-01 |
美商西爾拉癌症醫學公司 |
N-(氰基甲基)-4-(2-(4-𠰌啉基苯基胺基)嘧啶-4-基)苯甲醯胺
|
|
WO2016059011A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
TWI712601B
(zh)
|
2015-02-20 |
2020-12-11 |
美商英塞特公司 |
作為fgfr抑制劑之雙環雜環
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
CA2980507A1
(en)
|
2015-03-24 |
2016-09-29 |
Public University Corporation Nagoya City University |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
CA2980493A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
EP3319968A1
(en)
|
2015-07-06 |
2018-05-16 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
WO2017007756A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc |
Hetero-halo inhibitors of histone deacetylase
|
|
JP6847099B2
(ja)
|
2015-09-29 |
2021-03-24 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な大環状スルホンジイミン化合物
|
|
ES2819869T3
(es)
|
2015-10-08 |
2021-04-19 |
Bayer Pharma AG |
Nuevos compuestos macrocíclicos modificados
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
JP6697074B2
(ja)
|
2015-10-12 |
2020-05-20 |
チョン クン ダン ファーマシューティカル コーポレーション |
ヒストン脱アセチル化酵素６阻害剤としてのオキサジアゾールアミン誘導体化合物及びこれを含有する薬剤学的組成物
|
|
KR20250047404A
(ko)
|
2015-12-08 |
2025-04-03 |
바이오매트리카 인코포레이티드 |
적혈구 침강 속도의 감소
|
|
EP3492462B1
(en)
|
2016-07-26 |
2023-08-30 |
Shenzhen TargetRx, Inc. |
Amino pyrimidine compound for inhibiting protein tyrosine kinase activity
|
|
EP3509586A4
(en)
*
|
2016-09-12 |
2020-05-06 |
Imago Pharmaceuticals, Inc. |
TREATMENT OF FIBROTIC DISORDERS WITH JUN N-TERMINAL KINASE INHIBITORS
|
|
HUE057849T2
(hu)
|
2017-01-11 |
2022-06-28 |
Alkermes Inc |
Hiszton deacetiláz biciklusos gátlói
|
|
WO2018152223A1
(en)
*
|
2017-02-15 |
2018-08-23 |
University Of Massachusetts |
Methods of treating angiogenesis-related disorders using jnk3 inhibitors
|
|
GB201702947D0
(en)
|
2017-02-23 |
2017-04-12 |
Domainex Ltd |
Novel compounds
|
|
ES2900199T3
(es)
|
2017-03-28 |
2022-03-16 |
Bayer Ag |
Novedosos compuestos macrocíclicos inhibidores de PTEFB
|
|
EP3601236A1
(en)
|
2017-03-28 |
2020-02-05 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
GB201705263D0
(en)
*
|
2017-03-31 |
2017-05-17 |
Probiodrug Ag |
Novel inhibitors
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
LT3664802T
(lt)
|
2017-08-07 |
2022-06-27 |
Alkermes, Inc. |
Bicikliniai histonų deacetilazės inhibitoriai
|
|
SG11202003407VA
(en)
*
|
2017-10-17 |
2020-05-28 |
Merck Patent Gmbh |
PYRIMIDINE TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
|
|
AU2018352701A1
(en)
*
|
2017-10-17 |
2020-06-04 |
Merck Patent Gmbh |
Pyrimidine ΤΒΚ/ΙΚΚE inhibitor compounds and uses thereof
|
|
WO2019133810A1
(en)
|
2017-12-28 |
2019-07-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
|
MX2020008447A
(es)
|
2018-02-13 |
2020-09-28 |
Bayer Ag |
Uso de 5-fluoro-4-(4-fluoro-2-metoxifenil)-n-{4-[(s-metilsulfonimi doil)metil]piridin-2-il}piridin-2-amina para el tratamiento del linfoma difuso de celulas grandes b.
|
|
HRP20241288T1
(hr)
|
2018-05-04 |
2024-12-06 |
Incyte Corporation |
Čvrsti oblici fgfr inhibitora i postupci za njihovu proizvodnju
|
|
AU2019262579B2
(en)
|
2018-05-04 |
2024-09-12 |
Incyte Corporation |
Salts of an FGFR inhibitor
|
|
JP7447098B2
(ja)
*
|
2018-09-25 |
2024-03-11 |
カーデュリオン・ファーマシューティカルズ・インコーポレイテッド |
アミノピリミジン化合物
|
|
WO2020068846A1
(en)
*
|
2018-09-25 |
2020-04-02 |
Heterocyclic Compound |
Heterocyclic compound
|
|
PY19106549A
(es)
*
|
2018-12-21 |
2021-07-13 |
Bayer Ag |
1,3,4-oxadiazoles y derivados de éstos como nuevos agentes fungicidas
|
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2021050700A1
(en)
*
|
2019-09-13 |
2021-03-18 |
The Broad Institute, Inc. |
Cyclooxygenase-2 inhibitors and uses thereof
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
CA3157361A1
(en)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
WO2021076728A1
(en)
|
2019-10-16 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
JP7832891B2
(ja)
|
2019-12-04 |
2026-03-18 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤の誘導体
|
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
JP7587113B2
(ja)
*
|
2020-09-29 |
2024-11-20 |
日亜化学工業株式会社 |
異方性磁性粉末の製造方法および異方性磁性粉末
|
|
WO2022221170A1
(en)
|
2021-04-12 |
2022-10-20 |
Incyte Corporation |
Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
|
|
CA3220155A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
US11939331B2
(en)
|
2021-06-09 |
2024-03-26 |
Incyte Corporation |
Tricyclic heterocycles as FGFR inhibitors
|
|
US12084453B2
(en)
|
2021-12-10 |
2024-09-10 |
Incyte Corporation |
Bicyclic amines as CDK12 inhibitors
|
|
TW202547502A
(zh)
*
|
2024-05-13 |
2025-12-16 |
新加坡商阿諾醫藥(新加坡)有限公司 |
內醯胺結構ｃｄｋ抑制劑化合物
|